Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Behavioral Health Care Deals Rebound in Q3:17

Behavioral Health Care Deals Rebound in Q3:17

The Behavioral Health Care sector has gained a lot of attention from private investors in recent years, thanks to the opioid addiction epidemic, in general, and to legislation such as the Mental Health Parity and Addiction Equity Act, in particular. Here is how deal volume looked in the third quarter of 2017, and the preceding four quarters. Deal activity rose in Q3:17, up 63% compared with the previous quarter, and up 86% compared with the same quarter a year earlier. The quarter’s total of 13 deals represents 29% of the 45 transactions announced in the past 12 months. The first quarter of 2017 benefitted from the passage of the 21st Century Cures Act in December 2016, which brought... Read More »
Stat of the Week: Q3:17 Dollar Volume -57%

Stat of the Week: Q3:17 Dollar Volume -57%

The Health Care M&A Report, Third Quarter 2017 is going to press, and we wanted to share a few relevant statistics. Following robust spending in the second quarter, the third quarter’s total is 57% lower. Here’s the chart. Deal value in the third quarter totaled $42.7 billion, which was 57% lower than the previous quarter, and 13% lower than Q3:16’s $48.9 billion total. Deals on the Technology side of health care usually take the lion’s share of spending in each quarter, and that held true in the third quarter. Technology deals accounted for 59% ($25.3 billion) of the quarter’s spending. The Services sectors contributed 41% ($17.4 billion) of the period’s spending. In... Read More »
Top 10 Transactions in Q3:17

Top 10 Transactions in Q3:17

Ten of the largest deals announced in the third quarter broke the $1.0 billion mark, for a total of $29.9 billion (70% of the quarter’s total spending of $42.7 billion). The largest transaction, Gilead Sciences’ $11.9 billion acquisition of biotech firm Kite Pharma, made up 28% of the quarter’s combined total spending. KKR & Co. made three of these billion-dollar acquisitions, either directly or through portfolio companies, for a total of nearly $7.3 billion. All three targets were publicly traded companies in very discrete fields: internet healthcare source WebMD, air ambulance company American Medical Response, and the... Read More »

Health Care M+A Weekly Deals, The Week Ending October 13, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care     Acquirer Target Price The Halifax Group Delphi Behavioral Health Group, LLC N/A Lee Equity and FFL Partners Summit Behavioral Healthcare LLC N/A       Biotechnology    ... Read More »
Azalea Health Adds to its EMR Offerings

Azalea Health Adds to its EMR Offerings

Digital health deals are on track to surpass 2016’s record 157 transactions. Through mid-October, 139 deals have been announced in this sector, targeting companies specializing in revenue cycle management, telemedicine and electronic medical records (EMRs). Just four companies have made more than one acquisition this year, indicating there are more buyers getting into digital health than leaving it. Among the four serial acquirers this year are Allscripts (NASDAQ: MDRX), Azalea Health, NextGen Healthcare Information (NASDAQ: QSII) and contract research organization PRA Health Sciences (NASDAQ: PRAH). Azalea Health is the only the privately held digital health company to announce... Read More »
Stat of the Week: Q3:17 Dollar Volume -57%

Stat of the Week: Q3:17 Deal Volume Down 10%

As third quarters go in the cycle of healthcare mergers and acquisitions, big news is not expected. First quarter results may be exciting if the previous year’s fourth quarter was so hectic that a number of deals were pushed into the next year. Second quarters are usually a pause for breath as more books begin to circulate, indicating sellers’ interest in closing a deal by the end of the year. Third quarters tend to stay quiet, or even go dormant. Holidays and vacations are blamed, but for many deal makers, it’s a time to study and gird for the fourth quarter, when regulatory and tax deadlines sometimes loom. Preliminary results for Q3:17 show it is following the typical pattern. With 334... Read More »

CryoLife Misses Q3 Revenues, Buys JOTEC

Third quarter earnings season is off to a bad start for Cryolife, Inc. (NYSE:CRY), maker of medical devices and tissue processing systems focused on cardiac and vascular surgery. CRY stock slumped on Wednesday, October 11, when the company reported Q3 revenues of $45.1 million, well below its previously announced guidance of $46.5 million to $47.5 million. Not even an acquisition turned the stock northward, and it stayed down about 16% throughout the day. On October 10, Cryolife announced the acquisition of German medical device developer JOTEC AG, which makes technologically differentiated endovascular stent grafts, and cardiac and vascular surgical grafts, focused on... Read More »
Deal of the Week: Express Scripts Diversifies

Deal of the Week: Express Scripts Diversifies

Express Scripts (NASDAQ: ESRX) didn’t hedge its bets that online retail giant Amazon will enter the prescription drug delivery market.  On October 10, the leading pharmacy benefit manager (PBM) acquired South Carolina-based eviCore healthcare from its current investors, including General Atlantic, TA Associates, and Ridgemont Equity Partners, for $3.6 billion. The deal follows rumors that Amazon is contemplating entering the prescription drug delivery market in an attempt to improve price transparency for consumers and reduce out-of-pocket costs.  Last April, Express Scripts lost Anthem, Inc. (NYSE: ANTM) as a client, and with it, 18% of annual revenue. The threat of... Read More »
Third Quarter Long-Term Care M&A Results Are In

Third Quarter Long-Term Care M&A Results Are In

We will be addressing the quarterly seniors housing and healthcare M&A results in Health Care M&A Quarterly Report, which covers all 13 health care sectors. But, here is a preview: Although it remained above 70 deals for the quarter, seniors housing and care M&A activity fell to a year-low, tying with last year’s third quarter at 71 publicly announced transactions. Dollar volume also fell from its recent peak of $9.7 billion in the second quarter of 2017, recording $2.5 billion in transaction value based on disclosed prices. Increasingly, we have seen buyers prefer the one-off deals that come with one or two properties. Those deals are easier to complete and are most... Read More »

Health Care M+A Weekly Deals, The Week Ending October 6, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care     Acquirer Target Price D’Amore Healthcare, Inc. Pat Moore Foundation N/A Biotechnology     Acquirer Target Price Gesynta Pharma AB Rights to OX-MPI program N/A BlueRock... Read More »